Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Completed1
unknown1
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed125%
unknown125%
withdrawn125%
not_yet_recruiting125%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

Protective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery

NCT06728605
unknown

Impact of Enhanced External Counterpulsation (EECP) on Cardiac Force Index

NCT05080023
completednot_applicable

Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis

NCT01106495
withdrawnnot_applicable

Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX

NCT02517671

Clinical Trials (4)

Showing 4 of 4 trials
NCT06728605Not Applicable

Protective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery

Not Yet Recruiting
NCT05080023

Impact of Enhanced External Counterpulsation (EECP) on Cardiac Force Index

Unknown
NCT01106495Not Applicable

Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis

Completed
NCT02517671Not Applicable

Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4